Cargando…

Drug-induced comorbidities in patients with sarcoidosis

Sarcoidosis is a chronic multisystemic inflammatory disease of unknown aetiology with a wide range of highly variable clinical manifestations and unpredictable disease course. Sarcoidosis patients may present with specific organ-related symptoms involving functional impairments, and less specific sy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Drent, Marjolein, Jessurun, Naomi T., Wijnen, Petal A., Bekers, Otto, Bast, Aalt
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	SARCOIDOSIS: Edited by Ogugua Ndili Obi and Mareye Voortman
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451917/ https://www.ncbi.nlm.nih.gov/pubmed/35855576 http://dx.doi.org/10.1097/MCP.0000000000000889

Ejemplares similares

The role of PET in the management of sarcoidosis
por: Vender, Robert J., et al.
Publicado: (2022)

Hit-hard and early versus step-up treatment in severe sarcoidosis
por: Vorselaars, Adriane D.M., et al.
Publicado: (2022)

Tamsulosin Associated with Interstitial Lung Damage in CYP2D6 Variant Alleles Carriers
por: Jessurun, Naomi T., et al.
Publicado: (2020)

Role of Drug–Gene Interactions and Pharmacogenetics in Simvastatin-Associated Pulmonary Toxicity
por: Jessurun, Naomi T., et al.
Publicado: (2021)

Comparison of a 22G Crown-Cut Needle with a Conventional 22G Needle with EBUS Guidance in Diagnosis of Sarcoidosis
por: Wälscher, J., et al.
Publicado: (2022)

Multiple Correspondence Analysis and HLA-Associations of Organ Involvement in a Large Cohort of African-American and European-American Patients with Sarcoidosis
por: Rasmussen, Astrid, et al.
Publicado: (2023)

VKORC1 and CYP2C9 Polymorphisms: A Case Report in a Dutch Family with Pulmonary Fibrosis
por: Wijnen, Petal, et al.
Publicado: (2019)

Anti-inflammatory Properties of the Alpha-Melanocyte-Stimulating Hormone in Models of Granulomatous Inflammation
por: Shahraki, Abdolrazagh Hashemi, et al.
Publicado: (2022)

Multimodality Imaging to Diagnose Isolated Cardiac Sarcoidosis and Determine Regional Inflammatory Activity Levels
por: Au, Kenneth, et al.
Publicado: (2017)

Are infectious diseases risk factors for sarcoidosis or a result of reverse causation? Findings from a population-based nested case–control study
por: Rossides, Marios, et al.
Publicado: (2020)

Comorbidities of sarcoidosis
por: Tana, Claudio, et al.
Publicado: (2022)

Moderate or Severe Impairment in Pulmonary Function is Associated with Mortality in Sarcoidosis Patients Infected with SARS‑CoV‑2
por: Morgenthau, Adam S., et al.
Publicado: (2020)

A predictive tool for an effective use of (18)F-FDG PET in assessing activity of sarcoidosis
por: Mostard, Rémy LM, et al.
Publicado: (2012)

Increased circulating desmosine and age-dependent elastinolysis in idiopathic pulmonary fibrosis
por: de Brouwer, Bart, et al.
Publicado: (2018)

Self-reported Gastrointestinal Side Effects of Antifibrotic Drugs in Dutch Idiopathic Pulmonary Fibrosis patients
por: Proesmans, V. L. J., et al.
Publicado: (2019)

Ranking Self-reported Gastrointestinal Side Effects of Pharmacotherapy in Sarcoidosis
por: Drent, M., et al.
Publicado: (2020)

Prevalence of interstitial and other lung diseases on Aruba
por: Deenstra, Duco, et al.
Publicado: (2017)

Benefit of Wearing an Activity Tracker in Sarcoidosis
por: Drent, Marjolein, et al.
Publicado: (2020)

Sarcoidosis in a patient clinically diagnosed with silicosis; is silica associated sarcoidosis a new phenotype?
por: Beijer, Els, et al.
Publicado: (2019)

Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis
por: Erckens, R. J., et al.
Publicado: (2011)

The effects of vitamin E or lipoic acid supplementation on oxyphytosterols in subjects with elevated oxidative stress: a randomized trial
por: Baumgartner, Sabine, et al.
Publicado: (2017)

Determination of the smallest detectable change (SDC) and the minimal important difference (MID) for the Small Fiber Neuropathy Screening List (SFNSL) in sarcoidosis
por: Voortman, Mareye, et al.
Publicado: (2018)

Management of neurosarcoidosis: a clinical challenge
por: Voortman, Mareye, et al.
Publicado: (2019)

Methotrexate in sarcoidosis: hematologic and hepatic toxicity encountered in a large cohort over a six year period
por: Baughman, Robert P., et al.
Publicado: (2020)

Comorbidity of Leishmania Major with Cutaneous Sarcoidosis
por: Moravvej, Hamideh, et al.
Publicado: (2014)

World Association for Sarcoidosis and Other Granulomatous Disease (WASOG) Centers of Excellence
por: Baughman, Robert P, et al.
Publicado: (2021)

Sarcoidosis and Work Participation: The Need to Develop a Disease-Specific Core Set for Assessment of Work Ability
por: Hendriks, C. M. R., et al.
Publicado: (2019)

Sarcoidosis and increased risk of comorbidities and mortality in sweden
por: Larsson, Johanna, et al.
Publicado: (2020)

Infection prevention in sarcoidosis: proposal for vaccination and prophylactic therapy
por: Syed, Huzaefah, et al.
Publicado: (2020)

Oxidative Stress and Vascular Function: Implications for Pharmacologic Treatments
por: Weseler, Antje R., et al.
Publicado: (2010)

Masquelier’s grape seed extract: from basic flavonoid research to a well-characterized food supplement with health benefits
por: Weseler, Antje R., et al.
Publicado: (2017)

Targeted Knockout of Eukaryotic Translation Initiation Factor 4E Confers Bymovirus Resistance in Winter Barley
por: Hoffie, Robert Eric, et al.
Publicado: (2021)

Glutathione revisited: a better scavenger than previously thought
por: Haenen, Guido R. M. M., et al.
Publicado: (2014)

How COVID-19 impacted surplus food redistribution in the Netherlands: An explorative study
por: Rao, Madhura, et al.
Publicado: (2022)

The Burden of Sarcoidosis Symptoms from a Patient Perspective
por: Voortman, M., et al.
Publicado: (2019)

Correction to: The Burden of Sarcoidosis Symptoms from a Patient Perspective
por: Voortman, M., et al.
Publicado: (2019)

The iNs and Outs of Direct Reprogramming to Induced Neurons
por: Carter, Jasmine L., et al.
Publicado: (2020)

Risk and outcome of COVID-19 infection in sarcoidosis patients: results of a self-reporting questionnaire
por: Baughman, Robert P., et al.
Publicado: (2020)

Pain and autonomic dysfunction in patients with sarcoidosis and small fibre neuropathy
por: Bakkers, M., et al.
Publicado: (2010)

Impacts of RNA Mobility Signals on Virus Induced Somatic and Germline Gene Editing
por: Beernink, Bliss M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ef8nh1p199k1u2na69plbhqe1o